PerkinElmer, Inc. (United States)
(NYSE : PKI)

( )
PKI PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. 1.67%478.981.0%$1030.84m
DHRDanaher Corp. -0.10%224.770.7%$662.85m
MDTMedtronic Plc 1.28%113.580.6%$544.53m
BSXBoston Scientific Corp. 1.49%34.151.0%$524.34m
ABTAbbott Laboratories -0.32%108.140.8%$516.98m
BDXBecton, Dickinson & Co. 1.30%241.751.0%$422.29m
ISRGIntuitive Surgical, Inc. 2.40%751.282.3%$402.45m
DXCMDexCom, Inc. 1.67%333.207.8%$368.29m
ALGNAlign Technology, Inc. 1.08%505.486.4%$339.97m
BAXBaxter International, Inc. 1.11%76.351.8%$299.54m
SYKStryker Corp. 1.36%234.131.3%$285.09m
QDELQuidel Corp. 5.31%198.987.7%$236.23m
AAgilent Technologies, Inc. -0.68%114.581.6%$228.59m
EWEdwards Lifesciences Corp. 0.69%84.460.4%$227.46m
IDXXIDEXX Laboratories, Inc. -1.13%462.593.8%$211.75m

Company Profile

PerkinElmer, Inc. engages in the provision of products, services, and solutions for diagnostics, food, environmental, life sciences, and applied markets. It operates through the following segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment comprises of technologies that help life sciences researchers better understand diseases and develop treatments. The Diagnostics segment offers instruments, reagents, assay platforms, and software to hospitals, medical labs, clinicians, and medical research professionals to help improve the health of families. The company was founded by Richard Scott Perkin and Charles W. Elmer on April 19, 1937 and is headquartered in Waltham, MA.